BNP Paribas Asset Management
VERA icon

BNP Paribas Asset Management’s Vera Therapeutics VERA Stock Holding History

BNP Paribas Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31M Sell
147,030
-6,205
-4% -$231K 0.01% 829
2026
Q1 		$6.16M Sell
153,235
-1,318
-0.9% -$56.8K 0.01% 810
2025
Q4 		$7.83M Buy
154,553
+154,137
+37,052% +$5.47M 0.01% 736
2025
Q3 		$12K Hold
416
– – ﹤0.01% 1583
2025
Q2 		$10K Buy
+416
New +$9.35K ﹤0.01% 1791

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BNP Paribas Asset Management's VERA Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Vera Therapeutics (VERA) stake by 4% in Q2 2026, selling an estimated $231K and leaving 147,030 shares worth $6.31M. The position accounts for 0.01% of the portfolio, ranked #829.

BNP Paribas Asset Management first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.83M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • BNP Paribas Asset Management held 147,030 shares of Vera Therapeutics worth $6.31M as of Q2 2026.
  • BNP Paribas Asset Management sold 6,205 Vera Therapeutics shares in Q2 2026, an estimated $231K.
  • Vera Therapeutics made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #829 holding.
  • BNP Paribas Asset Management first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Vera Therapeutics position peaked at $7.83M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.